InnoCore Pharmaceuticals at PODD Boston – Explore the Future of Long-Acting Injectables

We are excited to be present at the PODD in Boston on October 27-28!

Join Rob Steendam, CTO and co-founder of InnoCore Pharmaceuticals, for his presentation: “SynBiosys®: Long-Acting Injectable Microspheres and In Situ Forming Depots for Delivery of Peptides and Proteins”. Rob will share insights into how our biodegradable SynBiosys®  polymer platform enables sustained release of peptides and proteins – without the typical limitations of PLGA.

Enhance your api into a long-acting injectable

Both Rob Steendam and Martin Bakker will be available to discuss formulation science, delivery strategies, and how we can help overcome your challenges in developing long-acting peptide and protein therapeutics.

Let’s connect at the PODD and explore how SynBiosys® can support your next breakthrough.